CNS Biomarkers

CNS biomarkers are measurable indicators that provide insights into the diagnosis, progression, and treatment of central nervous system disorders. These biomarkers, derived from imaging, cerebrospinal fluid, blood, or genetics, help detect conditions like Alzheimer's, multiple sclerosis, and Parkinson's at early stages. Advances in biomarker research enable precision medicine, guiding targeted therapies and monitoring treatment responses. By enhancing understanding of disease mechanisms, CNS biomarkers play a critical role in revolutionizing neurological care and improving patient outcomes.

 

    Related Conference of CNS Biomarkers

    February 04-05, 2026

    18th International Conference on Gynecology

    Rome, Italy
    March 09-10, 2026

    13th World Machine Learning and Deep learning Conference

    Singapore City, Singapore
    March 24-25, 2026

    9th Global Congress on Spine and Spinal Disorders

    Paris, France
    March 26-27, 2026

    12th World Congress on Anesthesia and Critical Care

    Amsterdam, Netherlands
    April 15-16, 2026

    9th Annual Meeting on Diabetes and Endocrinology

    Tokyo, Japan
    April 20-21, 2026

    47th International Summit on Human Anatomy & Physiology

    Barcelona, Spain
    April 27-28, 2026

    40th International Conference on Psychiatry and Mental Health

    Amsterdam, Netherlands
    April 27-28, 2026

    37th World Congress on Neurorehabilitation

    Dubai, UAE
    May 25-26, 2026

    18th International Conference on Clinical Chemistry

    Zurich, Switzerland
    September 14-15, 2026

    6th World Medicine Congress

    Rome, Italy
    November 24-25, 2026

    6th International Conference on Medical Research and Development

    Amsterdam, Netherlands
    November 25-26, 2026

    22nd World Summit on Blockchain Technology

    Amsterdam, Netherlands

    CNS Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in